Alys Pharmaceuticals

Alys Pharmaceuticals is an immuno-dermatology company with a robust pipeline of innovative programs and platforms targeting multiple dermatological indications. Formed from the merger of six asset-centric companies, Alys aims to redefine the treatment paradigm for various dermatological conditions using cutting-edge science and technologies.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $100M

Date: 12-Feb-2024

Investors: Medicxi

Markets: Immuno-dermatology, Biotechnology, Health Care, Pharmaceutical

HQ: Boston, Massachusetts, United States

Founded: 2024

Website: https://alyspharma.com/

LinkedIn: https://www.linkedin.com/company/alys-pharmaceuticals

Twitter:

Instagram: